Image
illustration
Venture Capital Acquisitions & Partnerships

Valo Health acquires TARA BIOSYSTEMS creating first of its kind vertically integrated cardiovascular platform

Tuesday 5 April, 2022
Body

The acquisition of TARA builds on Valo's extensive cardiovascular platform which already includes deep clinical human cardiovascular disease data giving the company a unique proprietary edge in cardiovascular drug discovery and development. TARA's state-of-the-art in vitro human cardiac disease models combined with Valo's artificial intelligence-driven Opal platform – which is built on high-fidelity patient data – creates a vertically integrated platform and a world-class cardiovascular disease franchise.

Content